Specify a stock or a cryptocurrency in the search bar to get a summary
Captor Therapeutics S.A.
60NCaptor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has various therapeutic molecules in the preclinical stage. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland. Address: ul. Dunska 11, Wroclaw, Poland, 54-427
Analytics
WallStreet Target Price
396.01 PLNP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 60N
Dividend Analytics 60N
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 60N
Stock Valuation 60N
Financials 60N
Results | 2019 | Dynamics |